Advancing the Development of a Human Schistosomiasis Vaccine.

Health Services / trends Humans Schistosomiasis / prevention & control Vaccines / administration & dosage
neglected tropical diseases schistosomiasis vaccine

Journal

Trends in parasitology
ISSN: 1471-5007
Titre abrégé: Trends Parasitol
Pays: England
ID NLM: 100966034

Informations de publication

Date de publication:
02 2019
Historique:
received: 18 09 2018
revised: 25 10 2018
accepted: 25 10 2018
pubmed: 21 11 2018
medline: 4 4 2019
entrez: 21 11 2018
Statut: ppublish

Résumé

Three vaccines against human schistosomiasis are in different phases of clinical development, and a fourth is expected to enter the clinic soon. Successful introduction of an efficacious preventive human schistosomiasis vaccine will require integration into existing health systems such as those that deliver childhood vaccines or mass drug administration programs.

Identifiants

DOI: 10.1016/j.pt.2018.10.005 PMID: 30455112
pubmed: 30455112
pii: S1471-4922(18)30236-8
doi: 10.1016/j.pt.2018.10.005
pii:
doi:

Substances chimiques

Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104-108

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Peter J Hotez (PJ)

Texas Children's Hospital Center for Vaccine Development, Departments of Pediatrics and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Department of Biology, Baylor University, Waco, TX, USA; James A. Baker III Institute of Public Policy, Rice University, Houston, TX, USA. Electronic address: hotez@bcm.edu.

Maria Elena Bottazzi (ME)

Texas Children's Hospital Center for Vaccine Development, Departments of Pediatrics and Molecular Virology and Microbiology, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, USA; Department of Biology, Baylor University, Waco, TX, USA.

Jeffrey Bethony (J)

Department of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washington, DC, USA.

David D Diemert (DD)

Department of Microbiology, Immunology, and Tropical Medicine, George Washington University, Washington, DC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Advancing the Development of a Human...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Advancing the Development of a Human...
questionsmedicales.fr › Infection › Maladies vectorielles › Schistosomiase › Advancing the Development of a Human...
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Advancing the Development of a Human...